185 related articles for article (PubMed ID: 24369060)
41. Targeted Delivery of siRNA Therapeutics using Ligand Mediated Biodegradable Polymeric Nanocarriers.
Cho KS; Hong SJ; Ahn MH; Pal S; Choung PH; Sangshetti J; Arote RB
Curr Pharm Des; 2018; 24(16):1788-1800. PubMed ID: 29962332
[TBL] [Abstract][Full Text] [Related]
42. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
43. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
44. Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA.
Reddy TL; Krishnarao PS; Rao GK; Bhimireddy E; Venkateswarlu P; Mohapatra DK; Yadav JS; Bhadra U; Bhadra MP
Int J Nanomedicine; 2015; 10():6411-23. PubMed ID: 26491299
[TBL] [Abstract][Full Text] [Related]
45. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
[TBL] [Abstract][Full Text] [Related]
46. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
47. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in nanoparticle-mediated siRNA delivery.
Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
[TBL] [Abstract][Full Text] [Related]
49. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
[TBL] [Abstract][Full Text] [Related]
50. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional targeting of small interfering RNAs into cancer cells.
Huynh T; Wälchli S; Sioud M
Biochem Biophys Res Commun; 2006 Dec; 350(4):854-9. PubMed ID: 17034763
[TBL] [Abstract][Full Text] [Related]
52. Strategies for in vivo siRNA delivery in cancer.
Sanguino A; Lopez-Berestein G; Sood AK
Mini Rev Med Chem; 2008 Mar; 8(3):248-55. PubMed ID: 18336345
[TBL] [Abstract][Full Text] [Related]
53. Biodegradable nano-polymeric system for efficient Akt1 siRNA delivery.
Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
J Nanosci Nanotechnol; 2010 May; 10(5):3366-9. PubMed ID: 20358958
[TBL] [Abstract][Full Text] [Related]
54. Target selectivity in mRNA silencing.
Aronin N
Gene Ther; 2006 Mar; 13(6):509-16. PubMed ID: 16520821
[TBL] [Abstract][Full Text] [Related]
55. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
56. Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.
Khan OF; Kowalski PS; Doloff JC; Tsosie JK; Bakthavatchalu V; Winn CB; Haupt J; Jamiel M; Langer R; Anderson DG
Sci Adv; 2018 Jun; 4(6):eaar8409. PubMed ID: 29963629
[TBL] [Abstract][Full Text] [Related]
57. Polymeric nanoparticles for siRNA delivery: Production and applications.
Cavallaro G; Sardo C; Craparo EF; Porsio B; Giammona G
Int J Pharm; 2017 Jun; 525(2):313-333. PubMed ID: 28416401
[TBL] [Abstract][Full Text] [Related]
58. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.
Liu F; Wang C; Gao Y; Li X; Tian F; Zhang Y; Fu M; Li P; Wang Y; Wang F
Mol Diagn Ther; 2018 Oct; 22(5):551-569. PubMed ID: 29926308
[TBL] [Abstract][Full Text] [Related]
59. Hyperbranched polymeric "star vectors" for effective DNA or siRNA delivery.
Nakayama Y
Acc Chem Res; 2012 Jul; 45(7):994-1004. PubMed ID: 22353143
[TBL] [Abstract][Full Text] [Related]
60. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
